Insights From 3 Unusual Cases
Eystein S Husebye
JCEM Case Reports, Volume 3, Issue 11, November 2025, luaf238
https://doi.org/10.1210/jcemcr/luaf238
Immune checkpoint inhibitors (ICIs) are monoclonal antibody drugs that have revolutionized cancer therapy and led to dramatically improved survival for aggressive cancers such as malignant melanoma and lung cancer. However, these benefits come with the cost of significant immune-related side effects. Endocrine glands are among those commonly affected, giving rise to potentially fatal complications if not promptly diagnosed and treated.
We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.
